유럽의 타겟 시퀀싱 시장 규모는 2023년 8억 380만 달러에 달했습니다.
이 시장은 2024년부터 2033년에 걸쳐 11.53%의 복합 연간 성장률(CAGR)로 확대되어 2033년에는 23억 7,330만 달러에 달할 것으로 예측되고 있습니다. 기존 기업과 신규 참가 기업이 시장 점유율을 다투고 있습니다.
| 주요 시장 통계 | |
|---|---|
| 예측 기간 | 2024년-2033년 |
| 2024년 평가 | 8억 8,880만 달러 |
| 2033년 예측 | 23억 7,330만 달러 |
| 복합 연간 성장률(CAGR) | 11.53% |
유럽의 타겟 시퀀싱 시장은 맞춤형 치료, 유전체 연구, 암이나 유전성 질환의 이환율 상승 등의 개발에 의해 대폭적인 증가가 예상되고 있습니다. 게 놈 영역을 조사하기 위한 정확하고 저렴한 기술인 타겟 시퀀싱의 이용이 증가하고 있습니다.
이 시장은 이 지역이 헬스케어의 혁신에 중점을 두고 있는 결과 성장하고 있어, 유전체 해석이나 바이오 테크놀로지 개발에 대한 투자가 그 후 밀어지고 있습니다. 강력한 건강 관리 시스템 그리고 유전체 연구에 대한 정부 보조금으로 타겟 시퀀싱 기술의 이용이 가속화되고 있습니다. 얻고 있습니다.
그럼에도 불구하고 엄청난 초기 비용, 복잡한 데이터 분석 및 규제 장벽과 같은 문제는 여전히 존재합니다. 해결하고 새로운 전망 를 창출할 것으로 기대되고 있습니다. 유럽의 타겟 시퀀싱 시장은 임상 및 연구 분야에서 수용이 진행되고 있기 때문에 유전체학와 프리시전 헬스케어의 진전에 빠뜨릴 수 없는 존재가 될 것으로 예상됩니다.
이 보고서는 유럽의 타겟 시퀀싱 시장을 조사했으며, 시장 개요와 함께 용도별, 제품 유형별, 타겟 엔리치먼트 법별, 타겟 캡처 유형별, 최종 사용자별, 국가별 동향 및 시장에 진입 하는 기업 프로파일 등의 정보를 제공합니다.
Introduction to Europe Targeted Sequencing Market
The Europe targeted sequencing market was valued at $803.8 million in 2023 and is expected to reach $2,373.3 million by 2033, growing at a CAGR of 11.53% between 2024 and 2033. The Europe targeted sequencing market is highly competitive, with established companies and new entrants vying for market share. The market's anticipated growth and evolution present a mix of challenges and opportunities, positioning it as a dynamic and rapidly changing landscape to monitor in the coming years.
Market Introduction
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2024 - 2033 |
| 2024 Evaluation | $888.8 Million |
| 2033 Forecast | $2,373.3 Million |
| CAGR | 11.53% |
The market for targeted sequencing in Europe is expected to increase significantly due to developments in customized treatment, genomic research, and the rising incidence of cancer and genetic disorders. Clinical diagnostics, medication development, and research applications are increasingly using targeted sequencing, a precise and affordable technique for examining particular genome regions. It is favored over conventional sequencing techniques because it may produce high-resolution data in less time and at a lower cost.
The market is growing as a result of the region's strong emphasis on healthcare innovation, which is bolstered by investments in genomics and biotechnological developments. Targeted sequencing technology use is accelerating in nations like Germany, the UK, and France thanks to strong healthcare systems and government funding for genomic research. Additionally, the market gains from the growing demand for personalized medicine and companion diagnostics, which rely heavily on precise genetic analysis.
Nevertheless, issues including exorbitant upfront expenses, intricate data interpretation, and regulatory barriers continue to exist. Nevertheless, it is anticipated that ongoing innovation, such as the fusion of bioinformatics and artificial intelligence, will resolve these issues and create new prospects. The targeted sequencing market in Europe is expected to be crucial to the advancement of genomics and precision healthcare due to its growing acceptance in the clinical and research sectors.
Market Segmentation
Segmentation 1: by Application
Segmentation 2: by End User
Segmentation 3: by Product Type
Segmentation 4: by Target Enrichment Method
Segmentation 5: by Target Capture
Segmentation 6: by Country
How can this report add value to an organization?
Workflow/Innovation Strategy: The Europe targeted sequencing market (by application) has been segmented into detailed segments of the application of targeted sequencing based on applications, including cancer, reproductive health, hereditary diseases, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases, and other applications.
Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enable prominent players to command premium prices while maintaining growth in revenue and volume.
Competitive Strategy: Key players in the Europe targeted sequencing market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe targeted sequencing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations are expected to aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.
Some of the prominent companies in this market are:
Scope and Definition
Company Profiles